Thông tin cho nhân viên y tế
Thuốc mới và thông tin từ Drugs.com
- MUMBAI, India and PRINCETON, N.J., July 26, 2024 /PRNewswire/ — Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries or associate companies) today…
- On July 22, 2024, the U.S. Food and Drug Administration (FDA) approved Femlyv (norethindrone acetate and ethinyl estradiol), the first orally disintegrating tablet approved for the prevention of pregnancy. Norethindrone acetate and ethinyl…
- RALEIGH, NC – July 23, 2024 — Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today the U.S. Food and Drug Administration (FDA) approved Xeomin (incobotulinumtoxinA) as the first and only neurotoxin…
- INCHEON, South Korea, July 22, 2024 (GLOBE NEWSWIRE) — Samsung Bioepis Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Epysqli (eculizumab-aagh) as a biosimilar to…
- Ahmedabad, India, 19 July 2024 Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval for its New Drug Application (NDA) from the United States Food and Drug…
- FLORHAM PARK, N.J., July 18, 2024 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today the U.S…
- FRIDAY, July 26, 2024 — Estimates of unintended pregnancy (UIP) among active-duty service women (ADSW) indicate a considerable impact on the ability to meet Women, Peace, and Security objectives, according to a study published online July 25 in…
- FRIDAY, July 26, 2024 — The closing line of the movie Barbie ("I'm here to see my gynecologist") may have spurred public interest in gynecology, according to a research letter published online July 25 in JAMA Network Open.Eva Senechal, from McGill…
- FRIDAY, July 26, 2024 — There are considerable disparities in the rate of unintentional firearms mortality across the 50 U.S. states and District of Columbia, with the highest rates clustered in the Southeast, according to a study published online…
- FRIDAY, July 26, 2024 — Wildfires raging across the western parts of the United States and Canada are prompting air quality alerts and evacuation orders. Smoke and haze have filled the skies in California, Oregon, Arizona, Washington, and several…
- FRIDAY, July 26, 2024 — Most prostate cancer outcomes do not differ significantly between transgender women (TGW) and cisgender (CG) men, including prostate cancer-specific mortality, according to a study published online July 21 in…
- FRIDAY, July 26, 2024 — Hydroxychloroquine appears to be a safe and effective treatment option for anogenital lichen sclerosus that only has mild adverse effects, according to a study published online July 19 in the International Journal of…
Thông tin từ The Pharma Letter
- The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended seven novel medicines for approval at its July 2024 meeting.
- An Analysis of M&A activity in the CNS space.
- In the UK, the health technology assessor has ruled in favor of reimbursing a new use for Merck & Co’s (NYSE: MRK) Keytruda (pembrolizumab).
- EMA Committee for Medicinal Products for Human Use (CHMP) has adopted a negative opinion on the marketing authorization approval (MAA) for the humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody Leqembi (lecanemab).
- The biopharmaceutical supply chain plays a pivotal role in ensuring the seamless delivery of therapeutics to patients. However, pharmaceutical supply chains face several challenges, including regulatory complexities, global competition, and the need for innovation.
- Belgian clinical-stage G-protein coupled receptor (GPCR) company Confo Therapeutics today announced the closing of a 60 million euros Series B financing
Thông tin từ BioPharmaDive
- All five large pharmaceutical companies to report earnings this week raised either their profit or revenue guidance for the year.
- Glycomimetics and Cue Biopharma both revealed layoffs. Elsewhere, AbbVie’s earnings impressed Wall Street and an FDA panel recommended changing testing requirements for some lung cancer drugs.
- Eisai plans to appeal the EMA’s negative recommendation, hoping to break into a market analysts expect could eventually bring billions of dollars in sales for the Alzheimer’s drug.
- CEO Thomas Schinecker claimed the company has “many opportunities” to stand out in the competitive field, and can get to market “much faster” than investors expect.
- Some analysts described Sanofi’s pipeline of immune system therapies, which includes more than half a dozen drugs in mid- to late-stage testing, as “underappreciated” by investors.
- The Stop Corporate Capture Act would codify the Chevron doctrine, which required federal courts to give deference to agencies’ reasonable interpretation of ambiguous statutes.
Thông tin từ STAT News
- From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
- Crisis Intervention Trainings should be mandatory for all police officers, and mental health crisis teams should be funded and deployed for de-escalation.
- The number of confirmed human infections with the bird flu virus associated with the ongoing outbreak in dairy cattle has risen to 13.
- A European Medicines Agency committee that evaluates new drugs recommended that Leqembi, an Alzheimer’s therapy from Eisai and Biogen, should be rejected.
- Shares of Dexcom plummeted nearly 40% in post-market trading yesterday, after the company lowered its full-year sales guidance. The maker of continuous glucose monitors is now forecasting $4 to $4.05…
- European regulators said that an Alzheimer’s therapy from Eisai and Biogen should be rejected, diverging from their U.S. counterparts, who have approved the medicine.
Thông tin từ Nature Review Drug Discovery
- Nature Reviews Drug Discovery, Published online: 25 July 2024; doi:10.1038/d41573-024-00125-0Opioid antidote gets a boost
- Nature Reviews Drug Discovery, Published online: 25 July 2024; doi:10.1038/d41573-024-00127-yProteogenomics identifies anticancer targets
- Nature Reviews Drug Discovery, Published online: 25 July 2024; doi:10.1038/d41573-024-00126-zOral miniproteins treat IBD
- Nature Reviews Drug Discovery, Published online: 25 July 2024; doi:10.1038/d41573-024-00128-xEpigenetic editor silences prion protein
- Nature Reviews Drug Discovery, Published online: 23 July 2024; doi:10.1038/d41573-024-00122-3Molecular glue degrader for sickle cell disease
- Nature Reviews Drug Discovery, Published online: 23 July 2024; doi:10.1038/d41573-024-00124-1AI reverse-engineers antibodies